Endocrine, Metabolic & Immune Disorders - Drug Targets
Title:AME Forthcoming Events 3rd AME UPDATE IN ENDOCRINOLOGIA ONCOLOGICA
Volume: 20 Issue: 3
Author(s):
Affiliation:
Export Options
About this article
Cite this article as:
, AME Forthcoming Events 3rd AME UPDATE IN ENDOCRINOLOGIA ONCOLOGICA, Endocrine, Metabolic & Immune Disorders - Drug Targets 2020; 20 (3) . https://dx.doi.org/10.2174/187153032003200324164729
DOI https://dx.doi.org/10.2174/187153032003200324164729 |
Print ISSN 1871-5303 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3873 |
14
1
1
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Management of Ovarian Cancer In Younger Women
Reviews on Recent Clinical Trials Smart Synthetic Polymer Nanocarriers for Controlled and Site-Specific Drug Delivery
Current Topics in Medicinal Chemistry In Silico Bioactivity Prediction of Methoxime-3,4-dephostatin Derivatives on Human PTP1B: Search for Novel Antidiabetic Leads
Letters in Drug Design & Discovery Cancer Treatment-Induced Cardiotoxicity: a Cardiac Stem Cell Disease?
Cardiovascular & Hematological Agents in Medicinal Chemistry Novel Neuroendocrine and Metabolic Mechanism Provides the Patented Platform for Important Rejuvenation Therapies: Targeted Therapy of Telomere Attrition and Lifestyle Changes of Telomerase Activity with the Timing of Neuron-Specific Imidazole-Containing Dipeptide-Dominant Pharmaconutrition Provision
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Glycosylation Pathways as Drug Targets for Cancer: Glycosidase Inhibitors
Mini-Reviews in Medicinal Chemistry Mechanism-Based Inactivators as Probes of Cytochrome P450 Structure and Function
Current Drug Metabolism The Application of lncRNAs in Cancer Treatment and Diagnosis
Recent Patents on Anti-Cancer Drug Discovery The Renin Angiotensin System in the Regulation of Angiogenesis
Current Pharmaceutical Design Umbilical IgE and Advanced Glycation Products in Association with Allergies in Childhood
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Molecular Docking for Identification of Potential Targets for Drug Repurposing
Current Topics in Medicinal Chemistry Common Genetic Variants of the Mitochondrial Trafficking System and Mitochondrial Uncoupling Proteins Affect the Development of Two Slowly Developing Demyelinating Disorders, Leukoaraiosis and Multiple Sclerosis
Current Medicinal Chemistry Low-Cost Anti-HIV Compounds: Potential Application for AIDS Therapy in Developing Countries
Current Pharmaceutical Design Modulation of Notch Signaling as a Therapeutic Approach for Liver Cancer
Current Gene Therapy Sequential and Asynchronous Strengthening of the Influence of Temperature on the Endo- and Exocytosis of Insulin in the Isolated Vertebrata Hepatocytes: Summing up Previous Studies
Current Protein & Peptide Science Significance of Pharmacogenetics and Pharmacogenomics Research in Current Medical Practice
Current Drug Metabolism Stability of Asp<sup>B28</sup> Insulin Exposed to Modified and Unmodified Polypropylene
Protein & Peptide Letters α-Glucosidase and α-Amylase Inhibition Study and <i>In Silico</i> Analysis of <i>Mimosa pudica</i> L. of Nepalese Origin
Current Bioactive Compounds Regulation of Gastric Nesfatin-1/NUCB2
Current Pharmaceutical Design Clinical Evidence of Intravitreal Triamcinolone Acetonide in the Management of Age-Related Macular Degeneration
Current Drug Targets